Inventor
PLE PATRICK
FR27 patents
⚠️ This page may combine multiple inventors who share the name “PLE PATRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
12 patentsUS7074800B1Jul 11, 2006
Quinazoline derivatives as angiogenesis inhibitors
ASTRAZENECA AB37 citations90
US8673906B2Mar 18, 2014
Chromenone derivatives
ASTRAZENECA AB17 citations88
US7141577B2Nov 28, 2006
Quinazoline derivatives
ASTRAZENECA AB11 citations84
US7049438B2May 23, 2006
Quinazoline derivatives for treatment of tumours
ASTRAZENECA AB14 citations84
US7696214B2Apr 13, 2010
Quinazoline derivatives for the treatment of tumours
ASTRAZENECA AB11 citations83
US9029374B2May 12, 2015
Chromenone derivatives
ASTRAZENECA AB5 citations82
US7462623B2Dec 9, 2008
Quinazoline derivatives as Src tyrosine kinase inhibitors
ASTRAZENECA AB8 citations74
US7973164B2Jul 5, 2011
Quinoline derivatives
ASTRAZENECA AB7 citations71
US6849625B2Feb 1, 2005
Quinazoline derivatives with anti-tumour activity
ASTRAZENECA AB11 citations71
US9718800B2Aug 1, 2017
Chromenone derivatives
ASTRAZENECA AB0 citations50
US6939866B2Sep 6, 2005
Quinazoline derivatives
ASTRAZENECA AB2 citations49
US7498335B2Mar 3, 2009
Method of producing an antiangiogenic or vascular permeability reducing effect
ASTRAZENECA AB0 citations39
ZENECA LTD
8 patentsUS6809097B1Oct 26, 2004
Quinoline derivatives inhibiting the effect of growth factors such as VEGF
ZENECA LTD76 citations98
US6294532B1Sep 25, 2001
Oxindolylquinazoline derivatives as angiogenesis inhibitors
ZENECA LTD87 citations98
US6265411B1Jul 24, 2001
Oxindole derivatives
ZENECA LTD95 citations98
US5482966AJan 9, 1996
Oxime derivatives
ZENECA LTD7 citations73
US5478842ADec 26, 1995
Ether derivatives having 5-lipoxygenase inhibitory activity
ZENECA LTD6 citations73
US5332757AJul 26, 1994
Oxime derivatives
ZENECA LTD14 citations73
US5453439ASep 26, 1995
Hydroxylamine derivatives
ZENECA LTD2 citations63
US5512594AApr 30, 1996
Ether derivatives having 5-lipoxygenase inhibitory activity
ZENECA LTD4 citations62